Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 28, 2025
Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

Medical Companies Segment Shows Strong Performance with +3.53% Weekly Growth

The medical companies segment has experienced a notable increase in performance, recording a weekly gain of +3.53%. This sector encompasses companies involved in the production and supply of pharmaceuticals and essential medical products, catering to a broad spectrum of healthcare needs. Their product offerings include surgical apparel, gloves, hospital furniture, fluid management solutions, and specialized equipment for cosmetic and surgical procedures. Key players within this sector include Cardinal Health, Hill-Rom Holdings, and Apyx Medical, each contributing to this segment’s impressive growth trajectory.

Market Capitalization in the Medical Segment

The average market capitalization across this group of medical companies stands at an impressive $26.8 billion. The companies within this segment vary widely in size, with market capitalizations ranging from $2.7 billion to a high of $53.2 billion. Welltower Inc. (WELL) is the largest player in the group, with a valuation of $53.2 billion, while Inari Medical (NARI) has the smallest market cap, standing at $2.7 billion. This diversity in market cap reflects the varying scales of companies in the sector, from large established firms to more specialized, smaller enterprises.

Price Growth Analysis

Over the past week, the average price growth across the segment’s stocks was 3.53%. When observed over a monthly period, the price growth averaged out at 0.7%, while the quarterly price growth demonstrated a more substantial increase of 15.09%. The weekly growth highlights some notable outperformers within the group:

  • Molina Healthcare (MOH): This stock showed an outstanding weekly price growth of +11.79%.
  • Cardinal Health (CAH): CAH also had a positive week, recording a +6.69% increase in price, reaching $103.39.
  • Inari Medical (NARI): NARI experienced a significant price jump of +9.15%, reflecting strong investor interest.

Conversely, Cardinal Health, despite being among the weekly gainers, did have a minimal fall of 0.21% over a longer monthly period, signaling some volatility within the broader uptrend.

Notable Price Movement Announcements

  • August 2, 2024: Cardinal Health (CAH) marked a +6.69% weekly price increase, solidifying its position as a top gainer in the segment.
  • July 26, 2024: Molina Healthcare (MOH) posted an impressive weekly gain of +12.66%, reflecting strong investor confidence.
  • July 2, 2024: Inari Medical (NARI) also achieved a +9.15% weekly gain, further bolstering the overall segment's performance.

Volume Trends in the Medical Segment

Examining volume trends offers additional insight into investor activity within this sector. The average weekly volume growth across the segment declined by -11.53%, indicating some moderation in trading activity. However, this trend changes over a longer timeframe, with the average monthly volume growth surging by 104.57% and quarterly volume growth increasing by 59.5%. This spike in volume over the past quarter suggests heightened investor interest, potentially driven by favorable developments or an optimistic outlook for the sector.

Key Volume Movement Announcements:

  • September 21, 2024: Welltower Inc. (WELL) saw a remarkable single-day volume increase, hitting 215% of its 65-day volume moving average.
  • June 1, 2024: Molina Healthcare (MOH) experienced three consecutive days of elevated trading volume, achieving a peak of 226% above its 65-day volume moving average.
  • March 29, 2024: Inari Medical (NARI) had an impressive surge in trading volume, reaching 824% above its 65-day volume moving average for a single day.

These substantial increases in volume may suggest significant investor actions, such as institutional buys or elevated market interest following major announcements or earnings reports.

Technical Indicators: Positive Momentum and Buy Signals

Several technical indicators suggest potential upward movement in key stocks within the segment, providing signals for potential buying opportunities.

          1. Molina Healthcare (MOH) Breaks Lower Bollinger Band

On October 17, 2024, Molina Healthcare's stock dipped below its lower Bollinger Band, a technical indicator that often signals an upward correction. Historically, in 27 out of 32 instances when MOH's price broke its lower Bollinger Band, the stock price rose in the following month. With an 84% probability of an upward trend, this pattern suggests that MOH may see positive price action soon, potentially making it an attractive candidate for traders considering buying the stock or exploring call options.

          2. Momentum Indicator Turns Positive for Welltower (WELL)

Welltower's Momentum Indicator moved above zero on October 15, 2024, signaling a possible new upward trend. This shift in momentum is typically an early indicator of positive price movement. Analyzing 86 previous instances where this indicator turned positive, the stock rose in 60 cases, giving a 70% likelihood of continued upward movement. Investors may see this as an opportunity to buy WELL shares or purchase call options, riding the potential bullish momentum.

          3. Stochastic Oscillator Signals Potential Decline for Inari Medical (NARI)

On October 18, 2024, the Stochastic Oscillator for Inari Medical moved out of the overbought zone, signaling a possible bearish outlook. Historical data suggests that in 43 out of 54 similar instances, NARI's stock price declined following the exit from the overbought zone, indicating an 80% chance of a downward trend. This technical signal may prompt investors to adopt a defensive stance or consider selling NARI, as there’s a high probability of a short-term pullback.

Summary

The medical companies segment has shown robust performance, with an average weekly price gain of +3.53% and significant quarterly price growth of 15.09%. Companies within this sector, such as Cardinal Health, Molina Healthcare, and Inari Medical, have been at the forefront of this growth, benefiting from strong demand for medical supplies and healthcare services. As investors analyze this sector, they are likely to consider both price and volume trends, along with technical indicators, to identify optimal entry and exit points for these stocks.

Molina Healthcare and Welltower currently exhibit positive momentum signals, suggesting potential buy opportunities, while Inari Medical’s technical indicators signal a possible retracement. With an average market capitalization of $26.8 billion and high trading volumes, this segment presents a dynamic environment for investors looking to gain exposure to the medical supply and healthcare industry.

Related Ticker: NARI, MOH, CAH, WELL
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a medical device company which develops, manufactures, markets and sells devices for the interventional treatment of venous diseases

Industry MedicalSpecialties

Profile
Details
Industry
N/A
Address
6001 Oak Canyon
Phone
+1 877 923-4747
Employees
1300
Web
https://www.inarimedical.com
Interact to see
Advertisement
TSM’s upcoming earnings carry outsized importance for the semiconductor industry. As the world’s leading contract chip manufacturer, TSMC underpins AI innovation for customers such as Nvidia and Apple. Its results often serve as a bellwether for global chip demand, capacity constraints, and pricing trends.
Goldman Sachs (GS) is expected to report Q4 2025 EPS of $11.65 on revenue of $13.85 billion, reflecting steady results as investment banking activity continues to recover.
Citigroup (C) is expected to report Q4 2025 EPS of $1.58, representing a 17.9% year-over-year increase, with revenue projected at $20.95 billion, up 7%. Bank of America (BAC) consensus estimates call for Q4 EPS of $0.96, up from $0.82, on revenue of $27.74 billion, reflecting 9.45% growth. JPMorgan Chase (JPM) is forecast to deliver Q4 EPS of $4.86, a modest 0.95% increase, with revenue expected to rise 8.13% to $46.25 billion.
Wells Fargo (WFC) is expected to report Q4 2025 earnings on January 14, 2026, with consensus calling for EPS of $1.66, up 16.9% year over year, and revenue of approximately $21.66 billion, a 6.3% increase. Investor focus will center on net interest income stabilization, growth in fee-based businesses such as investment banking and mortgages, and credit provisioning in a lower-rate environment.
Wall Street expects Infosys Q3 FY2026 EPS of $0.20, based on estimates from eight analysts, with revenue forecast at ₹452.37 billion (approximately $5.45 billion), compiled from 33 analysts.
BitMine Immersion Technologies (BMNR) is set to report Q1 FY2026 earnings on January 16, 2026, with consensus estimates calling for EPS of $0.15 and revenue of approximately $79.3 million.
Bank of America (BAC) and Wells Fargo (WFC) will both report Q4 2025 earnings on January 14, 2026, creating a rare same-day, apples-to-apples comparison.
Citigroup (C) is set to report Q4 2025 earnings on January 14, 2026, making it the immediate catalyst in this comparison. HSBC Holdings (HSBC) will release its Full-Year 2025 results on February 25, 2026, positioning it as a medium-term earnings event.
Wells Fargo’s quarterly results carry broader significance because the bank serves as a key indicator of U.S. consumer and commercial banking conditions. Its earnings often influence sentiment toward the entire large-cap banking sector. After a stretch of improved market conditions and stronger capital markets activity, investors are looking for confirmation that profit momentum is sustainable rather than driven by a single favorable quarter.
Infosys (INFY) will report Q3 FY2026 results on January 14, 2026, making it the immediate catalyst in this comparison. Accenture (ACN) last reported Q1 FY2026 earnings on December 18, 2025, with its next update scheduled later in the fiscal quarter.
BMNR reported fiscal Q4 and full-year FY2025 results (ending August 31, 2025), with profitability heavily influenced by digital-asset accounting and treasury positioning. Full-year diluted EPS: $13.39; Net income attributable to common stockholders: $328.161 million.
M&T Bank (MTB) is expected to deliver Q4 2025 EPS of $4.44–$4.46, representing roughly 13% year-over-year growth, driven by improving net interest income as funding costs decline. PNC Financial Services Group (PNC) is projected to post Q4 EPS of $4.19–$4.23, supported by about 1.5% sequential NII growth from rate relief and steady loan demand. U.S. Bancorp (USB) is forecast to earn $1.19 per share, an 11.2% annual increase, with revenues estimated at $7.33 billion, up 5%.
Dash (DASH.X) has ignited the crypto market with a powerful mid-January 2026 breakout, rallying more than 125% in a single week and decisively outperforming fellow privacy coins such as Monero and Zcash. The surge was fueled by a sharp short squeeze that wiped out nearly $4.9 million in bearish positions, alongside a major catalyst: Dash’s integration with Alchemy Pay, enabling direct fiat purchases across 173 countries.
As 2026 gets underway, ether.fi’s governance token (ETHFI.X) is emerging as a focal point for traders seeking exposure to Ethereum’s rapidly expanding liquid restaking ecosystem. With total value locked climbing to $7.8 billion, ether.fi now ranks as the second-largest staking protocol after Lido, underscoring its growing influence in the Ethereum economy.
The Schwab U.S. Small-Cap ETF (SCHA) is holding firm near the $28 level as 2026 begins, even as broader markets remain volatile. While short-term price action has been uneven, underlying signals suggest the ETF may be setting up for a meaningful breakout as interest-rate cuts revive small-cap equities. Technical models highlight an unusually favorable risk-reward profile—up to 22:1—with long-term momentum strengthening despite near-term consolidation.
The Vanguard Small-Cap Value ETF (VB) is quietly standing out in what has been a turbulent start to 2026. While many small-cap segments have struggled, VB has shown notable resilience, including a 3.2% jump on January 14, driven by renewed buying interest in undervalued industrial and financial stocks. This divergence from broader small-cap weakness suggests early signs of mean reversion, particularly as incoming economic data points toward eventual interest-rate relief.
The Vanguard Russell 2000 ETF (VTWO) has entered 2026 with renewed technical strength, breaking through several key indicators that suggest a potential trend reversal. On January 2, 2026, VTWO’s Momentum Indicator moved decisively above zero, a signal often associated with the early stages of bullish cycles. This followed an earlier technical milestone in December 2025, when the 10-day moving average crossed above the 50-day, drawing attention from momentum and swing traders alike.
CAOS, the trading ticker for IRIS Energy Limited, is emerging as a standout performer in early 2026 as two powerful trends converge: Bitcoin’s renewed surge and explosive demand for AI-ready data infrastructure. As Bitcoin pushes higher and investors hunt for leveraged exposure to both crypto and artificial intelligence, CAOS has attracted increasing attention from retail and quantitative traders alike.
In a surprising development that has caught the attention of both retail traders and institutional quantitative desks, Rubicon Technology Inc. (NASDAQ: RBC) has surfaced as one of early 2026’s more compelling AI-driven momentum candidates. After a relatively quiet close to 2025, the Illinois-based materials company—long associated with synthetic sapphire technology—has begun to display unexpected price strength, triggering alerts across algorithmic trading platforms.
In January 2026, Dell Technologies (DELL) experienced a sharp pullback, sliding nearly 9% as investor concerns mounted over escalating memory costs. Shortages and price increases in DRAM and NAND have squeezed margins across Dell’s server and PC businesses. The pressure was amplified after management acknowledged at CES 2026 that AI-focused PC marketing underperformed expectations and that component constraints were “unprecedented.”